Nutrition & DietReview ArticlePaywall

Time-Restricted Eating Cuts Blood Sugar and Insulin Resistance in Developing Nations

A 26-cohort systematic review finds TRE reduces fasting glucose, insulin resistance, and body weight in LMIC populations — for free.

Monday, August 24, 2026 5 views
Published in Clin Med Insights Endocrinol Diabetes
A wooden dining table with a simple meal of rice, vegetables, and fruit, alongside a clock showing a 10-hour eating window marked on its face

Summary

Researchers from Ghana reviewed 26 study cohorts across India, China, Indonesia, Iran, Tunisia, and Brazil to assess whether limiting daily eating to a 6–10 hour window could improve metabolic health without costly dietary programs. The results were encouraging: time-restricted eating (TRE) consistently reduced fasting blood sugar, insulin resistance, and body weight. One longitudinal cohort showed HbA1c still 0.78% lower at 18 months, suggesting benefits can persist with continued adherence. Early molecular signals pointed to activation of AMPK/mTOR pathways — cellular energy sensors linked to longevity and metabolic regulation. Because TRE requires no special foods or supplements, the authors argue it is a practical, cost-free chronomedicine strategy for resource-limited settings facing rising rates of type 2 diabetes.

0:00--:--

Detailed Summary

Type 2 diabetes is surging across low- and middle-income countries (LMICs), yet calorie-counting and specialized dietary programs are often unaffordable or impractical in these settings. Time-restricted eating (TRE) — limiting food intake to a defined daily window without altering food quality or quantity — offers a potentially zero-cost metabolic intervention. This systematic review asks how well the evidence supports TRE in LMIC populations and what molecular mechanisms may underlie its effects.

The authors conducted a PRISMA 2020-compliant review drawing on PubMed, Scopus, and Web of Science. They included 28 reports from 26 unique cohorts spanning India, China, Indonesia, Iran, Tunisia, and Brazil. Eligible studies enrolled adults with metabolic conditions and required TRE windows of 6–10 hours. Risk of bias was evaluated using RoB 2.0 and ROBINS-I tools.

Across most included studies, TRE was associated with meaningful reductions in fasting blood glucose, insulin resistance, and body weight. A standout finding came from a longitudinal cohort reporting an HbA1c reduction of −0.78% that was sustained at 18 months, implying that metabolic benefits can compound with longer adherence rather than fading. One smaller study documented early AMPK/mTOR pathway activation within 20 days of starting TRE — molecular changes that overlap directly with longevity-associated cellular energy sensing and autophagy induction.

For clinicians and health-conscious individuals, the practical implication is significant: meal timing alone — with no changes to what is eaten — may deliver measurable metabolic improvements. This positions TRE as a scalable, equitable strategy in any resource environment. However, study heterogeneity was high, and some centers found TRE no superior to caloric restriction.

Important caveats apply: the review is based on a mix of RCTs and quasi-experimental designs, cohort sizes were generally small, and follow-up periods varied. The summary here is based on the abstract only, as the full text was not accessible.

Key Findings

  • TRE (6–10 hour eating windows) reduced fasting blood glucose and insulin resistance across most of 26 LMIC cohorts.
  • HbA1c remained 0.78% lower at 18 months in one cohort, suggesting durable glycemic benefit with sustained adherence.
  • Early AMPK/mTOR pathway activation was detected within 20 days of starting TRE — a longevity-linked molecular signal.
  • TRE requires no dietary changes or supplements, making it a viable zero-cost metabolic strategy in resource-limited settings.
  • Results were inconsistent across centers; TRE was not universally superior to conventional caloric restriction.

Methodology

PRISMA 2020-compliant systematic review of 28 reports from 26 cohorts in India, China, Indonesia, Iran, Tunisia, and Brazil, including RCTs and quasi-experimental designs. Risk of bias was assessed with RoB 2.0 and ROBINS-I; the review was pre-registered with PROSPERO.

Study Limitations

The summary is based on the abstract only, as the full text was not openly accessible. Study heterogeneity across designs, populations, and TRE protocols limits definitive conclusions, and some cohorts were small with short follow-up. The review acknowledges contradictory findings between centers regarding TRE's advantage over caloric restriction.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.

Enter your email to subscribe: